BackRegencell Bioscience Holdings Overview

Regencell Bioscience Holdings EBIT

EBIT (Earnings Before Interest and Taxes) analysis for RGC.

Quarterly EBIT

-$5.34M
↓ 188.11% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$11.35M
↓ 32.17% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin